We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLX icon
201
Clorox
CLX
$12.7B
$2.53M 0.1%
17,183
+2,120
+14% +$324K
MMM icon
202
3M
MMM
$94.3B
$2.53M 0.1%
17,203
-608
-3% -$89.3K
EPAC icon
203
Enerpac Tool Group
EPAC
$1.93B
$2.5M 0.1%
55,765
+47,479
+573% +$2.11M
VVV icon
204
Valvoline
VVV
$4.51B
$2.49M 0.1%
71,527
-162
-0.2% -$5.91K
ALLY icon
205
Ally Financial
ALLY
$13.3B
$2.46M 0.1%
67,448
-368
-0.5% -$13.6K
MTRN icon
206
Materion
MTRN
$6.04B
$2.42M 0.1%
29,687
-3,677
-11% -$347K
LIVN icon
207
LivaNova
LIVN
$4.2B
$2.42M 0.1%
61,642
+3,611
+6% +$162K
UFPI icon
208
UFP Industries
UFPI
$5.19B
$2.39M 0.1%
22,347
+90
+0.4% +$10K
EMN icon
209
Eastman Chemical
EMN
$8.42B
$2.36M 0.09%
26,731
-1,172
-4% -$111K
GS icon
210
Goldman Sachs
GS
$303B
$2.33M 0.09%
4,268
-1,258
-23% -$757K
BKNG icon
211
Booking.com
BKNG
$161B
$2.33M 0.09%
12,650
+225
+2% +$43K
DINO icon
212
HF Sinclair
DINO
$14.5B
$2.32M 0.09%
+70,529
New +$2.47M
COLL icon
213
Collegium Pharmaceutical
COLL
$956M
$2.32M 0.09%
77,676
+4,513
+6% +$138K
BAX icon
214
Baxter International
BAX
$14.2B
$2.31M 0.09%
67,599
-1,553
-2% -$50.8K
ASTH icon
215
Astrana Health
ASTH
$1.77B
$2.27M 0.09%
73,115
-1,214
-2% -$40.4K
DRI icon
216
Darden Restaurants
DRI
$24.4B
$2.24M 0.09%
10,775
-457
-4% -$88.2K
SNA icon
217
Snap-on
SNA
$21.5B
$2.21M 0.09%
6,569
-278
-4% -$94.5K
GIII icon
218
G-III Apparel Group
GIII
$1.5B
$2.2M 0.09%
80,621
+307
+0.4% +$8.91K
CYBR
219
DELISTED
CyberArk
CYBR
$2.18M 0.09%
6,436
+245
+4% +$88.1K
WEC icon
220
WEC Energy
WEC
$35.1B
$2.16M 0.09%
19,790
+16,329
+472% +$1.67M
STAG icon
221
STAG Industrial
STAG
$7.19B
$2.14M 0.09%
59,179
+89
+0.2% +$3.1K
RARE icon
222
Ultragenyx Pharmaceutical
RARE
$2.55B
$2.11M 0.08%
58,314
+16,310
+39% +$679K
PSX icon
223
Phillips 66
PSX
$81.4B
$2.11M 0.08%
17,092
-696
-4% -$85.8K
TGT icon
224
Target
TGT
$68B
$2.1M 0.08%
20,133
-1,013
-5% -$127K
MKC icon
225
McCormick & Company Non-Voting
MKC
$14.2B
$2.1M 0.08%
25,461
+1,522
+6% +$119K
7 8
9
10 11

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.